SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-20-037198
Filing Date
2020-11-16
Accepted
2020-11-16 12:05:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13G ea129952-sc13ga4etf_zynerba.htm SC 13G/A 54786
  Complete submission text file 0001213900-20-037198.txt   56401
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Subject) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88971 | Film No.: 201314834
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 MAPLE STREET SUITE 2 SUMMIT NJ 07901
Business Address 30 MAPLE STREET SUITE 2 SUMMIT NJ 07901 908-897-0513
ETF MANAGERS GROUP, LLC (Filed by) CIK: 0001645173 (see all company filings)

IRS No.: 383938178 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A